FRACTION-RCC: Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC) Meeting Abstract
| Authors: | Choueiri, T. K.; Kluger, H. M.; George, S.; Tykodi, S. S.; Kuzel, T. M.; Perets, R.; Nair, S.; Procopio, G.; Carducci, M. A.; Castonguay, V.; Folefac, E.; Lee, C. H.; Hotte, S. J.; Miller, W. H.; Saggi, S. S.; Gold, D.; Motzer, R. J.; Escudier, B. |
| Abstract Title: | FRACTION-RCC: Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 278s |
| Language: | English |
| ACCESSION: | WOS:000560368302264 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.5007 |
| Notes: | Meeting Abstract: 5007 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work